stockrowBaxter International Inc.
BAX Healthcare Medical Instruments & Supplies
Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024.
- Revenue
- +4.97%
- EPS
- +731.9%
- Free cash flow
- +255.6%
- Total debt
- −9.48%
Quarter to September 2026, against a year earlier
Follow BAX
Alert me
Baxter International Inc. (BAX) Revenue growth
Baxter International Inc.'s revenue growth over the twelve months to 30 September 2026 was 5.33%, down 0.4 percentage points from fiscal 2025 (5.72%). Over the past ten years it has ranged from −17.2% (fiscal 2022) to 5.72% (fiscal 2025) — the current reading is the highest in ten years. That is below the Medical Instruments & Supplies industry median of 8.97% and below the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 5.72% | 3.06 |
| FY2024 | 2.66% | (0.35) |
| FY2023 | 3.01% | 20.21 |
| FY2022 | −17.2% | (21.25) |
| FY2021 | 4.05% | 1.31 |
| FY2020 | 2.74% | 0.37 |
| FY2019 | 2.37% | (2.50) |
| FY2018 | 4.87% | 0.73 |
| FY2017 | 4.14% | 2.18 |
| FY2016 | 1.96% | 8.97 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 4.97% | (0.37) |
| Jun 2026 | 5.34% | 2.44 |
| Mar 2026 | 2.90% | (5.13) |
| Dec 2025 | 8.03% | 2.99 |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| RGEN Repligen Corporation compare | 13.8% |
| WST West Pharmaceutical Services, Inc. compare | 12.6% |
| ATR AptarGroup, Inc. compare | 8.97% |
| BLCO Bausch + Lomb Corporation compare | 8.88% |
| BAX Baxter International Inc. | 5.33% |
| COO The Cooper Companies, Inc. compare | 4.73% |
| ALGN Align Technology, Inc. compare | 4.42% |
| AVTR Avantor, Inc. compare | 0.92% |
| SOLV Solventum Corporation compare | −2.84% |
| Medical Instruments & Supplies industry median | 8.97% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on BAX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement